12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 426.2% to $23.31 during Tuesday’s regular session. Soleno Therapeutics’s stock is…
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Dow Tumbles 150 Points; US House Prices Rise in July
U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74% to 13,173.33. The S&P 500 also fell, dropping, 0.65% to 4,309.40.
Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?
Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ: ICPT) for
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 386.4% to $21.55 during Tuesday’s pre-market session. The company’s market cap…
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday’s Mid-Day Session
Gainers
MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Investors Eye CymaBay’s AFFIRM Study As Regulatory Uncertainties Ease
Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due to
Analyst Ratings for Intercept Pharma
Analysts have provided the following ratings for Intercept Pharma (NASDAQ:ICPT) within the last quarter: Bullish Somewhat Bullish Indifferent…
Earnings Scheduled For August 2, 2023
Companies Reporting Before The Bell
• Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earnings at $0.37 per share on revenue of $784.53 million.